Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

63%

5 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

4(57.1%)

N/A

1(14.3%)

Phase 4

1(14.3%)

Phase 2

1(14.3%)

7Total

Phase 3(4)

N/A(1)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06008197Phase 3Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Role: collaborator

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT06936709Phase 4Not Yet Recruiting

Perioperative Colchicine for TKA

Role: collaborator

NCT06033950Phase 3Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Role: collaborator

NCT04556227Not ApplicableRecruiting

Simultaneous Recumbent Cycling and Cognitive Training

Role: collaborator

NCT04350593Phase 3Completed

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Role: collaborator

NCT03801070Completed

Rad Predictors for WON

Role: collaborator

NCT00695240Phase 2Unknown

Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair

Role: lead

All 8 trials loaded